- Home
- OPRX vs LEO Comparison
OPRX vs LEO Comparison
Compare OPRX & LEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPRX
- LEO
- Stock Information
- Founded
- OPRX 2006
- LEO 1987
- Country
- OPRX United States
- LEO United States
- Employees
- OPRX N/A
- LEO N/A
- Industry
- OPRX Business Services
- LEO Trusts Except Educational Religious and Charitable
- Sector
- OPRX Consumer Discretionary
- LEO Finance
- Exchange
- OPRX Nasdaq
- LEO Nasdaq
- Market Cap
- OPRX 380.6M
- LEO 362.5M
- IPO Year
- OPRX N/A
- LEO N/A
- Fundamental
- Price
- OPRX $18.25
- LEO $6.28
- Analyst Decision
- OPRX Buy
- LEO
- Analyst Count
- OPRX 8
- LEO 0
- Target Price
- OPRX $11.81
- LEO N/A
- AVG Volume (30 Days)
- OPRX 373.4K
- LEO 200.2K
- Earning Date
- OPRX 11-12-2025
- LEO 01-01-0001
- Dividend Yield
- OPRX N/A
- LEO 4.01%
- EPS Growth
- OPRX N/A
- LEO N/A
- EPS
- OPRX N/A
- LEO 0.04
- Revenue
- OPRX $104,748,000.00
- LEO N/A
- Revenue This Year
- OPRX $17.92
- LEO N/A
- Revenue Next Year
- OPRX $10.91
- LEO N/A
- P/E Ratio
- OPRX N/A
- LEO $152.00
- Revenue Growth
- OPRX 25.89
- LEO N/A
- 52 Week Low
- OPRX $3.78
- LEO $4.98
- 52 Week High
- OPRX $20.70
- LEO $6.50
- Technical
- Relative Strength Index (RSI)
- OPRX 49.17
- LEO 65.26
- Support Level
- OPRX $17.45
- LEO $6.22
- Resistance Level
- OPRX $18.93
- LEO $6.29
- Average True Range (ATR)
- OPRX 1.14
- LEO 0.05
- MACD
- OPRX -0.24
- LEO -0.00
- Stochastic Oscillator
- OPRX 21.08
- LEO 66.67
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
About LEO BNY Mellon Strategic Municipals Inc.
BNY Mellon Strategic Municipals, Inc. is a diversified closed-end management investment company. The fund's investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. Its products are Equity and Fixed Income Mutual Funds, Retail Money Market Funds, Government/Treasury Money Market Funds, Institutional Money Market Funds, and others. BNY Mellon and its affiliates, including BNYM Investment Adviser, INA and others involved in the management, sales, investment activities, business operations or distribution of the Fund, are engaged in businesses and have interests other than that of managing the Fund.